MYC and neoplasm: Moreover, no significant association was found between the expression of either ECM markers and the GCB or non-GCB phenotype, CD5 expression, molecular aberrations for BCL2, BCL6 and MYC or the collected clinico-pathological parameters (gender, tumour site, and tumour stage).